[Letter: Hyperphosphatemia and hypocalcemia following treatment of reticulosarcoma].
D000368:Aged; D001002:Anuria / Q000139:chemically induced; D002118:Calcium / Q000097:blood; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D010710:Phosphates / Q000097:blood*; D014508:Urea / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014750:Vincristine / Q000627:therapeutic use
D010710:Phosphates; D014527:Uric Acid; D014750:Vincristine; D003520:Cyclophosphamide; D014508:Urea; D002118:Calcium
Hyperphosphatémie et hypocalcémie secondaires au traitement d'un réticulosarcome